Low serum cholesterol levels predict inferior prognosis and improve prognostic index scoring for peripheral T-cell lymphoma, unspecified

Leuk Res. 2021 Apr:103:106534. doi: 10.1016/j.leukres.2021.106534. Epub 2021 Feb 15.

Abstract

Peripheral T-cell lymphomas, unspecified (PTCL-U) is a heterogeneous group of non-Hodgkin lymphomas, arising from the transformation of mature, post-thymic T-cells. Prognostic index for PTCL-U (PIT) is based on Europeans and may not be applicable for Chinese PTCL-U patients. Besides, low circulating cholesterol concentration is associated with elevated cancer incidence and mortality. The purpose of our study was to assess the prognostic value of serum lipid levels in PTCL-U and improve PIT. We screened the prognostic factors associated with progression-free survival (PFS) and overall survival (OS) by multivariate Cox regression analysis in ninety-one enrolled patients. The results showed that low-level high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) were associated with unfavorable OS. Furthermore, we developed a new risk model, PITC, based on low-level HDL-C, LDL-C and PIT. In Chinese PTCL-U, PITC was superior to PIT in PFS and OS. In conclusion, serum cholesterol levels may be good candidates for predicting prognosis in PTCL-U.

Keywords: High−density lipoprotein cholesterol; Low−density lipoprotein cholesterol; PIT, prognosis; Peripheral t−cell lymphoma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Cholesterol, HDL / blood*
  • Cholesterol, LDL / blood*
  • Disease-Free Survival
  • Female
  • Humans
  • Lymphoma, T-Cell, Peripheral / blood*
  • Lymphoma, T-Cell, Peripheral / mortality*
  • Lymphoma, T-Cell, Peripheral / therapy
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Retrospective Studies
  • Survival Rate

Substances

  • Cholesterol, HDL
  • Cholesterol, LDL